Personal information

Activities

Employment (2)

Johns Hopkins University: Baltimore, Maryland, US

2021-10-01 to present | Assistant Professor (Oncology)
Employment
Source: Self-asserted source
Marina Baretti

Johns Hopkins University: Baltimore, MD, US

2019-07-01 to 2021-06-30 | Oncology Fellow (Oncology)
Employment
Source: Self-asserted source
Marina Baretti

Works (34)

Relationship of Hepatocellular Carcinoma Stage and Hepatic Function to Health-Related Quality of Life: A Single Center Analysis

Healthcare
2023-09-18 | Journal article
Contributors: Amol Gupta; Jane Zorzi; Won Jin Ho; Marina Baretti; Nilofer Saba Azad; Paige Griffith; Doan Dao; Amy Kim; Benjamin Philosophe; Christos Georgiades et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Data from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-07-20 | Preprint
Contributors: Stephanie L. Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G. Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

Data from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-07-20 | Preprint
Contributors: Stephanie L. Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G. Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

FIGURE 1 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-07-20 | Preprint
Contributors: Stephanie L. Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G. Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

FIGURE 1 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-07-20 | Preprint
Contributors: Stephanie L. Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G. Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

FIGURE 2 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-07-20 | Preprint
Contributors: Stephanie L. Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G. Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

FIGURE 2 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-07-20 | Preprint
Contributors: Stephanie L. Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G. Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

Figure S1 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-07-20 | Preprint
Contributors: Stephanie L. Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G. Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

Figure S1 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-07-20 | Preprint
Contributors: Stephanie L. Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G. Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

Cancer Research Communications
2023-07-20 | Journal article
Contributors: Stephanie L. Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G. Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

TABLE 1 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-07-20 | Preprint
Contributors: Stephanie L. Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G. Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

TABLE 1 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-07-20 | Preprint
Contributors: Stephanie L. Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G. Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

TABLE 2 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-07-20 | Preprint
Contributors: Stephanie L. Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G. Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

TABLE 2 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-07-20 | Preprint
Contributors: Stephanie L. Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G. Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

Table S1 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-07-20 | Preprint
Contributors: Stephanie L. Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G. Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

Table S1 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-07-20 | Preprint
Contributors: Stephanie L. Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G. Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

Data from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-06-29 | Preprint
Contributors: Stephanie L Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

Figure S1 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-06-29 | Preprint
Contributors: Stephanie L Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

Figure S1 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-06-29 | Preprint
Contributors: Stephanie L Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

Table S1 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-06-29 | Preprint
Contributors: Stephanie L Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

Table S1 from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

2023-06-29 | Preprint
Contributors: Stephanie L Alden; Mir Lim; Chester Kao; Daniel Shu; Amit G Singal; Anne Noonan; Paige Griffith; Marina Baretti; Won Jin Ho; Ihab Kamel et al.
Source: check_circle
Crossref

Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures

JCO Precision Oncology
2022-06 | Journal article
Contributors: Kabir Mody; Prerna Jain; Sherif M. El-Refai; Nilofer S. Azad; Daniel J. Zabransky; Marina Baretti; Rachna T. Shroff; R. Katie Kelley; Anthony B. El-Khouiery; Adam J. Hockenberry et al.
Source: check_circle
Crossref

Epigenetic modifiers synergize with immune-checkpoint blockade to enhance long-lasting antitumor efficacy

Journal of Clinical Investigation
2021-08-16 | Journal article
Contributors: Marina Baretti; Mark Yarchoan
Source: check_circle
Crossref

An analysis of genetic heterogeneity in untreated cancers

Nature Reviews Cancer
2019-11 | Journal article
Contributors: Johannes G. Reiter; Marina Baretti; Jeffrey M. Gerold; Alvin P. Makohon-Moore; Adil Daud; Christine A. Iacobuzio-Donahue; Nilofer S. Azad; Kenneth W. Kinzler; Martin A. Nowak; Bert Vogelstein
Source: check_circle
Crossref

The Significance of Ascites in Patients With Pancreatic Ductal Adenocarcinoma

Pancreas
2019-04 | Journal article
Part of ISSN: 0885-3177
Source: Self-asserted source
Marina Baretti

The role of epigenetic therapies in colorectal cancer

Current Problems in Cancer
2018-11 | Journal article
Part of ISSN: 0147-0272
Source: Self-asserted source
Marina Baretti

DNA mismatch repair in cancer

Pharmacology & Therapeutics
2018-09 | Journal article
Part of ISSN: 0163-7258
Source: Self-asserted source
Marina Baretti

Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study

Clinical Colorectal Cancer
2018-09 | Journal article
Part of ISSN: 1533-0028
Source: Self-asserted source
Marina Baretti

Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: Are we aware of the therapeutic impact of intratumor heterogeneity?

Cancer Biology & Therapy
2018-08-03 | Journal article
Contributors: M. Baretti; N. Personeni; A. Destro; A. Santoro; L. Rimassa
Source: check_circle
Crossref

Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications

Gastric Cancer
2017-05 | Journal article
Part of ISSN: 1436-3291
Part of ISSN: 1436-3305
Source: Self-asserted source
Marina Baretti

Pathological characterization of nivolumab-related liver injury in a patient with glioblastoma

Immunotherapy
2016-12 | Journal article
Part of ISSN: 1750-743X
Part of ISSN: 1750-7448
Source: Self-asserted source
Marina Baretti

Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice

Lung Cancer
2016-05 | Journal article
Part of ISSN: 0169-5002
Source: Self-asserted source
Marina Baretti

KRASmutation in lung metastases from colorectal cancer: prognostic implications

Cancer Medicine
2016-02 | Journal article
Part of ISSN: 2045-7634
Source: Self-asserted source
Marina Baretti

Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer

Digestive and Liver Disease
2015-10 | Journal article
Contributors: David Sefrioui; Nasrin Sarafan-Vasseur; Ludivine Beaussire; Marina Baretti; Alice Gangloff; France Blanchard; Florian Clatot; Jean-Christophe Sabourin; Richard Sesboüé; Thierry Frebourg et al.
Source: check_circle
Crossref